Compare CPIX & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPIX | ORIS |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | United States | China |
| Employees | N/A | 69 |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.6M | 1.3M |
| IPO Year | 2007 | N/A |
| Metric | CPIX | ORIS |
|---|---|---|
| Price | $3.09 | $0.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 136.9K | 91.8K |
| Earning Date | 06-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.70 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $42,010,949.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $152.96 |
| Revenue Growth | ★ 16.75 | N/A |
| 52 Week Low | $1.85 | $0.06 |
| 52 Week High | $6.27 | $1.87 |
| Indicator | CPIX | ORIS |
|---|---|---|
| Relative Strength Index (RSI) | 33.29 | 31.41 |
| Support Level | $2.78 | $0.11 |
| Resistance Level | $3.85 | $0.97 |
| Average True Range (ATR) | 0.32 | 0.13 |
| MACD | -0.13 | -0.04 |
| Stochastic Oscillator | 3.48 | 23.84 |
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).